Document:

THIS
NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED
UNDER SUCH ACT AND/OR APPLICABLE STATE SECURITIES LAWS, OR UNLESS THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL OR OTHER EVIDENCE,
REASONABLY SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.

 

NON-NEGOTIABLE
CONVERTIBLE PROMISSORY NOTE 

 

	$[      ]	[Date]

 

FOR
VALUE RECEIVED, the undersigned, Transportation And Logistics Systems, Inc. (the “Company”), promises to
pay to the order of [Name] (the “Holder”) the principal sum of [Dollar Amount] US Dollars ($[ ]), together
with interest as provided below, both principal and interest being payable at the address of the Holder specified herein or at
such other place as Holder may, from time to time, provided to the Company in writing. The loan proceeds from Holder shall be
used by the Company solely for Working Capital.

 

1.
Maturity & Payment. Commencing on April 11, 2019, and continuing on the eleventh (11th) day of each month
thereafter, payments of interest only on the outstanding principal balance of this Note shall be due and payable. Commencing on
October 11, 2019 and continuing on the eleventh (11th) day of each month thereafter through March 11, 2021, payments
of principal and interest shall made in accordance with the amortization schedule set forth on Exhibit A. If not sooner converted
as provided in Section 3, the principal amount of this Note and all accrued, but unpaid interest hereunder shall be due and payable
on the earlier to occur of (i) April 11, 2021 (the “Maturity Date”), or (ii) an Event of Default (as defined
below). The payment of all or any portion of the principal and accrued interest may be paid prior to the Maturity Date.

 

2.
Interest. Interest shall accrue with respect to the unpaid principal sum identified above until such principal is paid
or converted as provided below at a rate equal to eighteen percent (18%) per annum compounded annually commencing on the date
hereof. All past due principal and interest on this Note shall bear interest from maturity of such principal or interest (in whatever
manner same may be brought about) until paid at the lesser of (i) twenty percent (20%) per annum, or (ii) the highest non-usurious
rate allowed by applicable law. Notwithstanding the foregoing and all other provisions hereof, in no event shall the interest
payable hereon, whether before or after maturity, exceed the maximum interest which, under applicable law, may be charged hereon.

 

3.
Conversion. This Note may be converted by Holder at any time in principal amounts of $100,000 in accordance with the terms
herein by delivery of written notice to the Company, into that number of shares of common stock equal to the amount obtained by
dividing the portion of the aggregate principal amount of this Note that is being converted by $1.37 (the closing price per share
on the date hereof). This Note is convertible only in the sole discretion of Holder. Holder may elect to convert the Note as described
herein at any time up to and including the time that the Company presents the funds to Holder for payment.

 

4.
Mechanics of Conversion. The Company shall not be obligated to issue certificates evidencing the shares of the securities
issuable upon conversion in accordance with Section 3 hereof unless either (i) Holder delivers this Note to Company or its transfer
agent for cancellation by Company, or (ii) if Holder notifies Company or its transfer agent that this Note has been lost, stolen
or destroyed, Holder executes and delivers to the Company an agreement satisfactory to Company to indemnify Company from any loss
incurred by it in connection with such Note. Company shall, as soon as practicable after such delivery, or such agreement and
indemnification, issue and deliver at such office to Holder, a certificate or certificates for the securities to which Holder
shall be entitled and a check payable to Holder in the amount of any cash amounts payable as the result of a conversion into fractional
shares of the securities and for accrued interest on the Note, if applicable.

 

    	 		 

    	 

    

 

5.
Fractional Shares; Effect of Conversion. No fractional shares shall be issued upon conversion of this Note. In lieu of
Company’s issuing any fractional shares to Holder upon the conversion of this Note, Company shall pay to Holder an amount
equal to the product obtained by multiplying (i) the price per share at which this Note is converted into the equity securities
of Company pursuant Section 3 hereof by (ii) the fraction of a share not issued pursuant to the previous sentence. Upon conversion
of this Note in full and the payment of the amounts specified herein in connection with such conversion, Company shall be forever
released from all of its obligations and liabilities under this Note.

 

6.
Default; Remedies. An “Event of Default” shall constitute the occurrence of any one or more other following
conditions: (i) the Company’s breach of any term or condition of this Note, including, but not limited to, any failure to
pay any payment of principal or interest as and when due in accordance with the terms of this Note and such payment remains unpaid
for a period of five (5) business days following the due date thereof; (ii) any representation or warranty made by the Company
to the Holder under this Note proves to have been false in any material respect when made or furnished the Company (iii) the Company
shall (A) apply for or consent to the appointment of a receiver, trustee, liquidator or custodian of itself or of all or a substantial
part of its property, (B) admit in writing its inability to pay its debts generally as they mature, (C) make a general assignment
for the benefit of its or any of its creditors, (D) be dissolved or liquidated or (E) commence a voluntary case or other proceeding
seeking liquidation, reorganization or other relief with respect to itself or its debts under any bankruptcy, insolvency or other
similar law now or hereafter in effect or consent to any such relief or to the appointment of or taking possession of its property
by any official in an involuntary case or other proceeding commenced against it; or (iv) proceedings for the appointment of a
receiver, trustee, liquidator or custodian of the Company, or of all or a substantial part of the property thereof, or an involuntary
case or other proceedings seeking liquidation, reorganization or other relief with respect to the Company or the debts thereof
under any bankruptcy, insolvency or other similar law now or hereafter in effect shall be commenced and an order for relief entered
or such proceeding shall not be dismissed or discharged within sixty (60) days of commencement. Other than a default on any payments
due from Company to Holder hereunder, Holder shall provide written notice to the Company of any Event of Default and the Company
shall have thirty (30) days to cure such Event of Default following written notice of such Event of Default from Holder (or such
longer period as may be required to perform the requirement if the Company commences performance within said 30-day period and
thereafter diligently works to complete same). In the event of a default on any payment when due hereunder, Holder may declare
the entirety of this Note, principal and interest, immediately due and payable without any notice, demand, presentment for payment,
notice of non-payment, protest, notice of protest, notice of intention to accelerate or notice of acceleration, and failure to
exercise said option shall not constitute a waiver on the part of Holder of the right to exercise the same at any other time.

 

7.
Waivers by Company. Company waives demand, presentment, notice of protest, notice of demand, dishonor, diligence in collection
and notices of intention to accelerate maturity in connection with an Event of Default. Any such acceleration shall be automatically
effectuated by Company by making an entry to such effect in its records, in which event the unpaid balance on this Note shall
become immediately due and payable without demand or notice.

 

    	 	2	 

    	 

    

 

8.
Usury. All agreements between the Company and Holder, whether now existing or hereafter arising and whether written or
oral, are expressly limited so that in no contingency or event whatsoever, whether by acceleration of the maturity of this Note
or otherwise, shall the amount paid, or agreed to be paid, to Holder for the use, forbearance or detention of the money to be
loaned under this Note or otherwise, exceed the maximum amount permissible under applicable law. If from any circumstances whatsoever
fulfillment of any provision of this Note or of any other document evidencing, securing or pertaining to the indebtedness evidenced
by this Note, at the time performance of such provision shall be due, shall involve transcending the limit of validity prescribed
by law, then ipso facto, the obligation to be fulfilled shall be reduced to the limit of such validity, and if from any
such circumstances Holder shall ever receive anything of value as interest or deemed interest by applicable law under this Note
or any other document evidencing, securing or pertaining to the indebtedness evidenced by this Note or otherwise an amount that
would exceed the highest lawful rate, such amount that would be excessive interest shall be applied to the reduction of the principal
amount owing under this Note or on account of any other indebtedness of the Company to Holder relating to this Note, and not to
the payment of interest, or if such excessive interest exceeds the unpaid balance of principal of this Note and such other indebtedness,
such excess shall be refunded to the Company. In determining whether or not the interest paid or payable with respect to any indebtedness
of the Company to Holder, under any specific contingency, exceeds the highest lawful rate, the Company and Holder shall, to the
maximum extent permitted by applicable law, (i) characterize any nonprincipal payment as an expense, fee or premium rather than
as interest, (ii) amortize, prorate, allocate and spread the total amount of interest throughout the full term of such indebtedness
so that the actual rate of interest on account of such indebtedness is uniform throughout the term of such indebtedness, and/or
(iii) allocate interest between portions of such indebtedness, to the end that no such portion shall bear interest at a rate greater
than that permitted by law. The terms and provisions of this Section shall control and supersede every other conflicting provision
of all agreements between the Company and Holder. Each party has been advised by the other to seek the advice of an attorney and
an accountant in connection with the issuance of this Note. Each party has had the opportunity to seek the advice of any attorney
and accountant of such party’s choice in connection with issuance of this Note.

 

9.
Headings. The headings in this Note are for purposes of reference only and shall not limit or otherwise affect the meaning
hereof.

 

10.
Governing Law. This Note shall be construed in accordance with and governed by the internal laws of the State of New York
without regard to the conflicts of law principles thereof.

 

11.
Notices. All notices and other communications required or permitted under this Note shall be in writing and shall be delivered
personally by hand or by courier, mailed by United States first-class mail, postage prepaid, or sent by electronic mail directed
(a) if to the Holder, at the Holder’s address or electronic mail address set forth in the Subscription Agreement, or at
such other address or electronic mail address as the Holder may designate by ten (10) days’ advance written notice to the
Company or (b) if to the Company, to its address or electronic mail address set forth on its signature page to this Note and directed
to the attention of the President, or at such other address or electronic mail address as the Company may designate by ten (10)
days’ advance written notice to the Holder. All such notices and other communications shall be effective or deemed given
upon personal delivery, on the date of mailing or upon confirmation of electronic mail delivery. With respect to any notice given
by the Company under any provision of the Texas Business Organizations Code or any other governing document of the Company, the
Holder agrees that such notice may be given by electronic mail.

 

12.
Successors and Assigns. This Note is non-negotiable and may not be sold, assigned, or otherwise negotiated by either party
to any person or entity without the prior written consent of the non-assigning party, which the non-assigning party may withhold
in their sole reasonable discretion. Any purported transfer or assignment without such permission to assign or transfer any rights,
duties, or obligations that arise under this Note shall be void. Subject to the foregoing and except as otherwise provided herein,
the provisions of this Note shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors, and
administrators of the Company and the Holder.

 

	 	COMPANY:
	 	 
	 	Transportation
    And Logistics Systems, Inc.
	 	 
	 	
	 	Steve
    Yariv,
	 	Chief
    Executive Officer
	 	 
	 	Address:
	 	Transportation
    And Logistics Systems, Inc.
	 	2833
    Exchange Court, Suite A
	 	West
    Palm Beach, Florida 33409
	 	Attn:
    Chief Executive Officer
	 	Email:
    steve@dcat.com
	 	 

 

    	 	3	 

    	 

    

 

Exhibit
A

 

	Date	 	Interest	 	Principal	 	Payment
	April
    11, 2019	 	 	 	 	 	 
	May
    11, 2019	 	 	 	 	 	 
	June
    11, 2019	 	 	 	 	 	 
	July
    11, 2019	 	 	 	 	 	 
	August
    11, 2019	 	 	 	 	 	 
	September
    11, 2019	 	 	 	 	 	 
	October
    11, 2019	 	 	 	 	 	 
	November
    11, 2019	 	 	 	 	 	 
	December
    11, 2019	 	 	 	 	 	 
	January
    11, 2020	 	 	 	 	 	 
	February
    11, 2020	 	 	 	 	 	 
	March
    11, 2020	 	 	 	 	 	 
	April
    11, 2020	 	 	 	 	 	 
	May
    11, 2020	 	 	 	 	 	 
	June
    11, 2020	 	 	 	 	 	 
	July
    11, 2020	 	 	 	 	 	 
	August
    11, 2020	 	 	 	 	 	 
	September
    11, 2020	 	 	 	 	 	 
	October
    11, 2020	 	 	 	 	 	 
	November
    11, 2020	 	 	 	 	 	 
	December
    11, 2020	 	 	 	 	 	 
	January
    11, 2021	 	 	 	 	 	 
	February
    11, 2021	 	 	 	 	 	 
	March
    11, 2021	 	 	 	 	 	 

 

    	 	4Exhibit 10.1

 

Security pUrchase
AGREEMENT

This Security Purchase Agreement (this “Agreement”)
is made as of [_______], 2019 (the “Effective Date”) by and between Amyris, Inc., a Delaware corporation (the
“Company”), and [___________] (“Purchaser”).

1.     
Issuance of Securities. Effective as the Effective Date, the Company will issue and sell to Purchaser
(i) [_________] shares (the “Shares”) of the Company’s Common Stock, $0.0001 par value per share (the
“Common Stock”) and (ii) a warrant in the form attached hereto as Exhibit A (the “Warrant”),
registered in the name of the Purchaser, to purchase up to [________] shares of the Company’s Common Stock, with an exercise
price per share equal to $[_____], subject to adjustment therein (the “Warrant Shares” and, together with the
Shares and the Warrant, the “Securities”). Purchaser will purchase the Shares at a price of $[_____] per Share
in cash. The total purchase price payable by the Purchaser for the Securities is $[_______] (the “Total Purchase Price”).

2.     
Closing and Delivery.

(a)              
Closing. The closing (“Closing”) of the transactions contemplated hereby shall be held at the
offices of Fenwick & West LLP, 801 California Street, Mountain View, California 94041 within two Business Days of the date
of this Agreement (such date, the “Closing Date”), or at such other time and place as the Company and the Purchaser
mutually agree upon. “Business Day” shall mean any day except any Saturday, any Sunday, any day which is a federal
legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required
by law or other governmental action to close.

(b)              
Delivery. At the Closing, the Company shall execute and deliver to the Purchaser the Warrant and the Purchaser shall
pay the Company the applicable Total Purchase Price in immediately available funds. Promptly following the Closing, the Company
shall deliver to the Purchaser a single stock certificate representing the number of Shares purchased by the Purchaser, such stock
certificate to be registered in the name of the Purchaser, or in such nominee’s or nominees’ name(s) as designated
by the Purchaser in writing, against payment of the purchase price therefor by wire transfer of immediately available funds to
such account or accounts as the Company shall designate in writing to Purchaser.

3.     
Company Representations. The Company represents and warrants to Purchaser as follows:

(a)              
Organization and Standing. The Company is duly incorporated, validly existing, and in good standing under the laws
of the State of Delaware. The Company has all requisite power and authority to own and operate its properties and assets and to
carry on its business as presently conducted and as proposed to be conducted. The Company is qualified to do business as a foreign
entity in every jurisdiction in which the failure to be so qualified would have, or would reasonably be expected to have, a material
adverse effect, individually or in the aggregate, upon the business, properties, tangible and intangible assets, liabilities, operations,
prospects, financial condition or results of operation of the Company or the ability of the Company to perform its obligations
under the Transaction Agreements (a “Material Adverse Effect”).

     

     

    

(b)              
Power. The Company has all requisite power to execute and deliver this Agreement, to sell and issue the Securities
hereunder, and to carry out and perform its obligations under the terms of this Agreement and the Warrant (the “Transaction
Agreements”).

(c)              
Authorization. The execution, delivery, and performance of the Transaction Agreements by the Company has been duly
authorized by all requisite action on the part of the Company and its officers, directors and stockholders, and this Agreement
constitutes the legal, valid, and binding obligation of the Company enforceable in accordance with its terms, except (a) as limited
by applicable bankruptcy, insolvency, reorganization, moratorium, and other laws of general application affecting enforcement of
creditors’ rights generally, and (b) as limited by laws relating to the availability of specific performance, injunctive
relief or other equitable remedies (the “Enforceability Exceptions”). 

(d)              
Consents and Approvals. Except for any Current Report on Form 8-K or Notice of Exempt Offering of Securities on Form
D to be filed by the Company in connection with the transaction contemplated hereby, the Company is not required to give any notice
to, make any filing with, or obtain any authorization, consent, or approval of any government or governmental agency in order to
consummate the transaction contemplated by the Transaction Agreements. Assuming the accuracy of the representations of the Purchaser
in Section 4, no consent, approval, authorization or other order of, or registration, qualification or filing with, any court,
regulatory body, administrative agency, self-regulatory organization, stock exchange or market (including The Nasdaq Stock Market),
or other governmental body is required for the execution and delivery of the Transaction Agreements, the valid issuance, sale and
delivery of the Securities to be sold pursuant to this Agreement other than such as have been or will be made or obtained, or for
any securities filings required to be made under federal or state securities laws applicable to the offering of the Securities.

(e)              
Non-Contravention. Except as disclosed in Schedule 3(e), the execution and delivery of the Transaction Agreements,
the issuance, sale and delivery of the Securities to be sold by the Company under this Agreement, the performance by the Company
of its obligations under the Transaction Agreements and/or the consummation of the transaction contemplated hereby will not (a) conflict
with, result in the breach or violation of, or constitute (with or without the giving of notice or the passage of time or both)
a violation of, or default under, (i) any bond, debenture, note or other evidence of indebtedness, or under any lease, license,
franchise, permit, indenture, mortgage, deed of trust, loan agreement, joint venture or other agreement or instrument to which
the Company or any subsidiary is a party or by which it or its properties may be bound or affected, (ii) the Company’s
Restated Certificate of Incorporation, as amended and as in effect on the date hereof, the Company’s Bylaws, as amended and
as in effect on the date hereof, or the equivalent document with respect to any subsidiary, as amended and as in effect on the
date hereof, or (iii) any statute or law, judgment, decree, rule, regulation, ordinance or order of any court or governmental
or regulatory body (including The Nasdaq Stock Market), governmental agency, arbitration panel or authority applicable to the Company,
any of its subsidiaries or their respective properties, except in the case of clauses (i) and (iii) for such conflicts,
breaches, violations or defaults that would not be likely to have, individually or in the aggregate, a Material Adverse Effect,
or (b) result in the creation or imposition of any lien, encumbrance, claim, security interest or restriction whatsoever upon
any of the material properties or assets of the Company or any of its subsidiaries or an acceleration of indebtedness pursuant
to any obligation, agreement or condition contained in any material bond, debenture, note or any other evidence of indebtedness
or any material indenture, mortgage, deed of trust or any other agreement or instrument to which the Company or any if its subsidiaries
is a party or by which the Company or any of its subsidiaries is bound or to which any of the property or assets of the Company
is subject. For purposes of this Section 3(e), the term “material” shall apply to agreements, understandings, instruments,
contracts or proposed transactions to which the Company is a party or by which it is bound involving obligations (contingent or
otherwise) of, or payments to, the Company in excess of $100,000 in a 12-month period.

    	 	2	 

     

    

(f)               
Shares. The Shares are duly authorized and when issued pursuant to the terms of this Agreement will be validly issued,
fully paid, and nonassessable, and will be free of any liens or encumbrances with respect to the issuance thereof; provided,
however, that the Shares shall be subject to restrictions on transfer under state or federal securities laws as set forth
in this Agreement, or as otherwise may be required under state or federal securities laws as set forth in this Agreement at the
time a transfer is proposed. Except as disclosed in Schedule 3(f), the issuance and delivery of the Shares is not subject to preemptive,
co-sale, right of first refusal or any other similar rights of the stockholders of the Company or any other person, or any liens
or encumbrances or result in the triggering of any anti-dilution or other similar rights under any outstanding securities of the
Company.

(g)              
Authorization of the Warrants. The Warrants have been duly authorized by the Company and, when duly executed and
delivered by the Company, will constitute a valid and binding agreement of the Company, enforceable against the Company in accordance
with its terms, subject to the Enforceability Exceptions.

(h)              
Authorization of the Warrant Shares. The Warrant Shares issuable upon exercise of the Warrants have been duly authorized
and reserved for issuance upon exercise by all necessary corporate action and such shares, when issued upon such exercise in accordance
of the terms of the Warrants, will be validly issued and will be fully paid and non-assessable, and will be free of any liens or
encumbrances with respect to the issuance thereof; provided, however, that the Warrant Shares shall be subject to restrictions
on transfer under state or federal securities laws as set forth in this Agreement, or as otherwise may be required under state
or federal securities laws as set forth in this Agreement at the time a transfer is proposed. Except as disclosed in Schedule 3(f),
the issuance and delivery of the Warrant Shares is not subject to preemptive, co-sale, right of first refusal or any other similar
rights of the stockholders of the Company or any other Person, or any liens or encumbrances or result in the triggering of any
anti-dilution or other similar rights under any outstanding securities of the Company.

(i)                
No Registration. Assuming the accuracy of each of the representations and warranties of the Purchaser, the issuance
by the Company of the Securities is exempt from registration under the Securities Act of 1933, as amended.

    	 	3	 

     

    

4.     
Investment Representations. In connection with the receipt of the Securities pursuant to this Agreement,
Purchaser represents to the Company the following:

(a)              
The execution, delivery and performance by Purchaser of this Agreement do not and will not contravene or constitute a default
under, or violation of, or be subject to penalties under, (i) any agreement (or require the consent of any party under any such
agreement that has not been made or obtained) to which Purchaser is a party, or (ii) any judgment, injunction, order, decree or
other instrument binding upon Purchaser, except where such contravention, default, violation or failure to obtain a consent, individually
or in the aggregate, would not reasonably be expected to impair Purchaser’s ability to perform fully any obligation which
Purchaser has or will have under this Agreement.

(b)              
Purchaser understands the definition of the term “accredited investor” within the meaning of Regulation D,
Rule 501(a), promulgated by the SEC under the Securities Act of 1933, as amended (the “Securities Act”),
and qualifies as an accredited investor.

(c)              
Purchaser is aware of the Company’s business affairs and financial condition and has acquired sufficient information
about the Company to reach an informed and knowledgeable decision to acquire the Securities. Purchaser is acquiring the Securities
for investment for its own account only and not with a view to, or for resale in connection with, any “distribution”
thereof within the meaning of the Securities Act or under any applicable provision of state law. Purchaser does not have any present
intention to transfer the Securities to any other person or entity in such a “distribution.”

(d)              
Purchaser understands that the Securities have not been registered under the Securities Act by reason of a specific exemption
therefrom, which exemption depends upon, among other things, the bona fide nature of Purchaser’s investment intent as expressed
herein.

(e)              
Purchaser understands that the Securities are “restricted securities” under applicable U.S. federal and state
securities laws and that, pursuant to these laws, Purchaser must hold the Securities indefinitely unless they are registered with
the SEC and qualified by state authorities, or an exemption from such registration and qualification requirements is available.
Purchaser acknowledges that the Company has no obligation to register or qualify the Securities for resale.

(f)               
By reason of his business and financial experience, Purchaser has the ability to protect her own interests in connection
with the purchase of the Securities.

5.     
Restrictive Legends and Stop-Transfer Orders.

The certificate or certificates representing
the Securities shall bear such legends as the Company deems to be required for the purpose of compliance with applicable Federal
or state securities laws or as otherwise required by law.

    	 	4	 

     

    

6.     
Beneficial Ownership Limitation. 

The Company shall not effect any exercise
or conversion of any Company security, and the Purchaser shall not have the right to exercise or convert any portion of any Company
security, to the extent that after giving effect to such issuance after exercise or conversion, the Purchaser (together with the
Purchaser’s affiliates, and any other persons acting as a group together with the Purchaser or any of the Purchaser’s
affiliates (such Persons, “Attribution Parties”)), would beneficially own in excess of the Beneficial Ownership
Limitation (as defined below); provided, that the Beneficial Ownership Limitation shall not apply in the event that the
Company obtains stockholder approval for issuances of shares of Common Stock in excess of the Beneficial Ownership Limitation and
otherwise satisfies the requirements of Nasdaq Stock Market Rule 5635. For purposes of the foregoing sentence, the number of shares
of Common Stock beneficially owned by the Purchaser and Attribution Parties shall include the number of shares of Common Stock
issuable upon exercise or conversion of the Company security with respect to which such determination is being made, but shall
exclude the number of shares of Common Stock which would be issuable upon (i) exercise or conversion of the remaining, nonexercised
or nonconverted portion of the Company security to which such determination is being made that is beneficially owned by the Purchaser
or any of its Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities
of the Company subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned
by the Purchaser or any of its Attribution Parties. Except as set forth in the preceding sentence, beneficial ownership shall be
calculated in accordance with Section 13(d) of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”)
and the rules and regulations promulgated thereunder, it being acknowledged by the Purchaser that the Purchaser is solely responsible
for any schedules required to be filed in accordance therewith. In addition, a determination as to any group status as contemplated
above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.
For purposes of this Section 6, in determining the number of outstanding shares of Common Stock, the Purchaser may rely on the
number of outstanding shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed
with the U.S. Securities and Exchange Commission, as the case may be, (B) a more recent public announcement by the Company or (C)
a more recent written notice by the Company or the Company’s transfer agent setting forth the number of shares of Common
Stock outstanding. Upon the written or oral request of the Purchaser, the Company shall within two trading days confirm orally
and in writing to the Purchaser the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares
of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company by the Purchaser
or its Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The “Beneficial
Ownership Limitation” shall be 19.99% of the number of shares of the Common Stock outstanding.

7.     
Registration Rights.

(a)              
Company Registration. If at any time or from time to time the Company shall determine to register any of its equity
securities, either for its own account or for the account of security holders (other than (1) in a registration relating solely
to employee benefit plans, (2) a registration on Form S-4 or S-8 (or such other similar successor forms then in effect under the
Securities Act), (3) a registration pursuant to which the Company is offering to exchange its own securities, or (4) a registration
statement relating solely to dividend reinvestment or similar plans), the Company will:

    	 	5	 

     

    

(i)                
promptly (but in no event less than 10 days before the effective date of the relevant Registration Statement) give to the
Holder written notice thereof; and

(ii)             
include in such registration (and any related qualification under state securities laws or other compliance), and in any
underwriting involved therein, all the Registrable Securities specified in a written request or requests, made within 5 days after
receipt of such written notice from the Company, by the Holder, except as set forth in Section 7.b below

(b)              
Underwriting. If the registration of which the Company gives notice is for a registered public offering involving
an underwriting, the Company shall so advise the Holder as a part of the written notice given pursuant to Section 7.a(i). In such
event the right of any Holder to registration pursuant to this Section 7 shall be conditioned upon such Holder’s participation
in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided
herein. All Holders proposing to distribute their Registrable Securities through such underwriting shall, together with the Company
and the other parties distributing their securities through such underwriting, enter into an underwriting agreement in customary
form with the underwriter or underwriters selected for such underwriting by the Company. Notwithstanding any other provision of
this Section 7, if the underwriter determines that marketing factors require a limitation of the number of shares to be underwritten,
the underwriter may limit the number of Registrable Securities to be included in the registration and underwriting, subject to
the terms of this Section 7. The Company shall so advise all holders of the Company’s securities that would otherwise be
registered and underwritten pursuant hereto, and the number of shares of such securities, including Registrable Securities, that
may be included in the registration and underwriting shall be allocated first to the Company and second to the Holders and any
other holders with registration rights on a pro rata basis based on the total number of Registrable Securities held by the Holders
and such other holders. No such reduction shall (i) reduce the securities being offered by the Company for its own account to be
included in the registration and underwriting, or (ii) reduce the amount of securities of the selling holders included in the registration
below twenty-five percent (25%) of the total amount of securities included in such registration by all selling stockholders. No
securities excluded from the underwriting by reason of the underwriter’s marketing limitation shall be included in such registration.
For the avoidance of doubt, nothing in this Section 7.b is intended to diminish the number of securities to be included by the
Company in the underwriting.

(c)              
Registrable Securities. For purpose of this Section 7, “Registrable Securities” means (i) the Shares
and the Warrant Shares held by, or issuable to, the Holder and (ii) any shares of voting securities issued as (or issuable upon)
a stock split, stock dividend or other distribution with respect to, or in exchange or in replacement of, such Registrable Securities
set forth in clause (i), in each case, until the earliest to occur of (A) the date on which a registration statement covering such
securities has been declared effective by the SEC and such security has been disposed of pursuant to such effective registration
statement, (B) the date on which such security is sold pursuant to Rule 144, (C) the date on which such security ceases to be outstanding
or (D) the date on which the Holder thereof, together with its affiliates, is able to dispose of all of its Registrable Securities
in any 90 day period pursuant to Rule 144 (or any similar or analogous rule promulgated under the Securities Act).

    	 	6	 

     

    

8.     
Fees and Expenses. The Company shall pay the reasonable fees and expenses of Purchaser in connection
with the transactions contemplated hereby.

9.     
Miscellaneous.

(a)              
This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall
be governed, construed and interpreted in accordance with the laws of the State of California, without giving effect to principles
of conflicts of law.

(b)              
This Agreement may be executed in two counterparts, each of which shall be deemed an original and all of which together
shall constitute one instrument.

(c)              
The rights and benefits of this Agreement shall inure to the benefit of, and be enforceable by the Company’s successors
and assigns. The rights and obligations of Purchaser under this Agreement may only be assigned with the prior written consent of
the Company.

[Signature Pages Follow]

 

 

 

 

    	 	7	 

     

    

The undersigned has executed this Agreement as of the date first
set forth above.

		THE COMPANY:
	 	AMYRIS, INC.
	 	By:________________________
	 	(Signature)
	 	Name:_____________________
	 	Title:______________________
	 	 
	 	Address:
	 	5885 Hollis Street, Suite 100
	 	Emeryville, CA 94608
	 	Attention: General Counsel

 

 

 

[Signature Page to Securities Purchase Agreement]

     

     

    

The undersigned has executed this Agreement as of the date first
set forth above. 

		PURCHASER:
	 	[____________]  
	 	 
	 	___________________________________
	 	(Signature)
	 	Name:______________________________
	 	Title: ______________________________
	 	 
	 	Address:
	 	c/o         
	 	 
	 	 
	 	Attention:  
	 	Facsimile:  
	 	Email: 

 

 

 

[Signature Page to Common Stock Purchase Agreement]

     

     

    

EXHIBIT A

Form of Warrant

    	 	A-1	 

     

    

NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS
EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE
UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY,
MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE
EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED
INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

COMMON STOCK PURCHASE WARRANT

 

AMYRIS, INC. 

	Warrant Shares: [_______]	Issue Date: [______], 2019

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”)
certifies that, for value received, [_______] or its assigns (the “Holder”) is entitled, upon the terms and
subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial
Exercise Date”) and on or prior to the close of business on the two (2) year anniversary of the Initial Exercise Date
(the “Termination Date”) but not thereafter, to subscribe for and purchase from Amyris, Inc., a Delaware corporation
(the “Company”), up to [_______] ([_______]) shares (as subject to adjustment hereunder, the “Warrant
Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise
Price, as defined in Section 2(b).

Section 1.Definitions.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the “Purchase Agreement”), dated [_______], 2019, among the Company and the Holder.

Section 2.Exercise.

a)                 
Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part,
at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of
a duly executed facsimile copy or PDF copy submitted by electronic (or e-mail attachment) of the Notice of Exercise in the form
annexed hereto (“Notice of Exercise”). Within two (2) Trading Days following the date of exercise as aforesaid,
the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer
or cashier’s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is
specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee
(or other type of guarantee or notarization) of any Notice of Exercise form be required. Notwithstanding anything herein to the
contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all
of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender
this Warrant to the Company for cancellation within three (3) Trading Days of the date the final Notice of Exercise is delivered
to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available
hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to
the applicable number of Warrant Shares purchased. The Company shall maintain records showing the number of Warrant Shares purchased
and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Business Day of
receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of
the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares
available for purchase hereunder at any given time may be less than the amount stated on the face hereof.

    	 	1	 

     

    

b)                 
Exercise Price. The exercise price per share of the Common Stock under this Warrant shall be $[____], subject to
adjustment hereunder (the “Exercise Price”).

c)                 
Cashless Exercise. Notwithstanding anything contained herein to the contrary, if a registration statement covering
the resale of the Warrant Shares subject to the applicable Notice of Exercise is not available for the resale of such Warrant Shares,
at any time after the six month anniversary of the Initial Exercise Date, this Warrant may be exercised, in whole or in part, at
any time or times on or after the Initial Exercise Date and on or before the Termination Date at the election of the Holder (in
such Holder’s sole discretion) by means of a “cashless exercise” in which the Holder shall be entitled to receive
a number of Warrant Shares equal to the quotient obtained by dividing ((A-B) * (X)) by (A), where:

(A) = as applicable: (i) the VWAP on the
Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed
and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to
Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours” (as defined in Rule 600(b)(64)
of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either
(y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the
Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder’s execution of the
applicable Notice of Exercise if such Notice of Exercise is executed during “regular trading hours” on a Trading Day
and is delivered within two (2) hours thereafter (including until two (2) hours after the close of “regular trading hours”
on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date
of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a)
hereof after the close of “regular trading hours” on such Trading Day;

 

    	 	2	 

     

    

(B) = the Exercise Price of this Warrant,
as adjusted hereunder; and

 

(X) = the number of Warrant Shares
that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means
of a cash exercise rather than a cashless exercise.

 

If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9)
of the Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period
of the Warrant Shares being issued may be tacked on to the holding period of this Warrant.  The Company agrees not to
take any position contrary to this Section 2(c).

 

“Bid Price” means,
for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b)  if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common
Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in the “Pink
Sheets” published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting
prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value
of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable
to the Company, the fees and expenses of which shall be paid by the Company.

 

“VWAP” means, for any
date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted
on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day
from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)  if OTCQB or OTCQX is not a Trading Market, the
volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then
reported in the “Pink Sheets” published by OTC Markets Group, Inc. (or a similar organization or agency succeeding
to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all
other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith
by the Holder and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

    	 	3	 

     

    

Notwithstanding anything herein to the
contrary, on the Termination Date, if a registration statement covering the resale of the Warrant Shares is not available for the
resale of the Warrant Shares, this Warrant shall be automatically exercised via cashless exercise pursuant to this Section 2(c).

 

d)        
Mechanics of Exercise.

		i.	Delivery of Warrant Shares Upon Exercise. Warrant Shares purchased hereunder shall be transmitted
by the Transfer Agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with
The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is
then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant
Shares to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without
volume or manner-of-sale limitations pursuant to Rule 144, and otherwise by physical delivery of a certificate, registered in the
Company’s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder
is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the
earlier of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise and (ii) one (1) Trading Day after
delivery of the aggregate Exercise Price to the Company (such date, the “Warrant Share Delivery Date”). Upon
delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of
the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares,
provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within two (2)
Trading following delivery of the Notice of Exercise. The Company agrees to maintain a transfer agent that is a participant in
the FAST program so long as this Warrant remains outstanding and exercisable.

ii.                    
Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at
the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver
to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant,
which new Warrant shall in all other respects be identical with this Warrant.

iii.                 
Rescission Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares
pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.

    	 	4	 

     

    

iv.                 
Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights
available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance
with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after
such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder’s brokerage
firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which
the Holder anticipated receiving upon such exercise (a “Buy-In”), then the Company shall (A) pay in cash to
the Holder the amount, if any, by which (x) the Holder’s total purchase price (including brokerage commissions, if any) for
the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the
Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order
giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the
Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed
rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied
with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price
giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be
required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder
in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s
right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company’s failure to timely deliver shares of Common Stock upon
exercise of the Warrant as required pursuant to the terms hereof.

v.                 
No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon
the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such
exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal
to such fraction multiplied by the Exercise Price or round up to the next whole share.

    	 	5	 

     

    

vi.                 
Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue
or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses
shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may
be directed by the Holder; provided, however, that in the event that Warrant Shares are to be issued in a name other
than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto
duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it
for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any
Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar
functions) required for same-day electronic delivery of the Warrant Shares.

vii.                 
Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the timely
exercise of this Warrant, pursuant to the terms hereof.

e)                 
Holder’s Exercise Limitations. Notwithstanding anything to the contrary contained herein, the Company shall
not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant
to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable
Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other Persons acting as a group together with
the Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)), would beneficially
own in excess of the Beneficial Ownership Limitation (as defined below); provided, that the Beneficial Ownership Limitation
shall not apply in the event that the Company obtains stockholder approval for issuances of shares of Common Stock in excess of
the Beneficial Ownership Limitation and otherwise satisfies the requirements of Nasdaq Stock Market Rule 5635.  For purposes
of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and Attribution Parties shall
include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is
being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining,
nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii)
exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation,
any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein
beneficially owned by the Holder or any of its Affiliates or Attribution Parties.  Except as set forth in the preceding sentence,
for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act
and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Holder is solely responsible
for any schedules required to be filed in accordance therewith. In addition, a determination as to any group 

    	 	6	 

     

    

status as contemplated
above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.
For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number
of outstanding shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with
the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.  Upon the written or oral
request of a Holder, the Company shall within two Trading Days confirm orally and in writing to the Holder the number of shares
of Common Stock then outstanding.  In any case, the number of outstanding shares of Common Stock shall be determined after
giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates
or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The “Beneficial
Ownership Limitation” shall be 19.99% of the number of shares of the Common Stock outstanding immediately after giving effect
to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The limitations contained in this paragraph shall
apply to a successor holder of this Warrant.

Section 3.Certain Adjustments.

a)     
Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend
or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities
payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company
upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines
(including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues by
reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price
shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares,
if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding
immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted
such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a)
shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend
or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

b)     
[INTENTIONALLY OMITTED]

    	 	7	 

     

    

c)     
Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time after
the Original Issue Date the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants,
securities or other property pro rata to the record holders of any class of shares of Common Stock (the “Purchase Rights”),
then each Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights
which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations on exercise hereof) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of
shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights.

d)     
Pro Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any
dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of
return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or
options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction,
but excluding any dividend that results in adjustment to the Conversion Price pursuant to Section 3(a) above) (a “Distribution”),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock
acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof) immediately before the
date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders
of shares of Common Stock are to be determined for the participation in such Distribution.

e)     
Fundamental Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly,
in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell,
tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the
outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification,
reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively
converted into or exchanged for other securities, cash or property, or (v) the Company, 

    	 	8	 

     

    

directly or indirectly, in one or more
related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation,
a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person or group of Persons whereby such other
Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held
by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to,
such stock or share purchase agreement or other business combination) (each a “Fundamental Transaction”), then,
the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately
prior to the occurrence of such Fundamental Transaction (as if the exercise of the Warrant occurred immediately prior to the occurrence
of such Fundamental Transaction), at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise
of this Warrant), the number of shares of common stock of the successor or acquiring corporation or shares of Common Stock of the
Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant
is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise
of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to
apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common
Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in
a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder
shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental
Transaction.

f)      
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a
share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding
as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

g)     
Notice to Holder.

i.     
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3,
the Company shall within two (2) Trading Days deliver to the Holder by facsimile or email a notice setting forth the Exercise Price
after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts
requiring such adjustment.

    	 	9	 

     

    

ii.     
Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever
form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common
Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase
any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required
in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale
or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock
is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution,
liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile
or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company,
at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date
on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record
is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale,
transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the
Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable
upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such
notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified
in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant
to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the
date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

Section 4.Transfer of Warrant.

a)     
Transferability. Subject to compliance with any applicable securities laws and the conditions set forth in Section
4(d) hereof and to the provisions of Section 4(a) of the Warrant Exercise Agreement, this Warrant and all rights hereunder are
transferable, in 

    	 	10	 

     

    

whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent,
together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its
agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender
and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or
assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue
to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.
Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company
unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within
three (3) Trading Days of the date the Holder delivers an assignment form to the Company assigning this Warrant full. The Warrant,
if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having
a new Warrant issued.

b)     
New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid
office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued,
signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved
in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or
Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated
the original issue date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

c)     
Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that
purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may
deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any
distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

d)     
Transfer Restrictions. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant,
the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities
Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions
or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer,
that the Holder or transferee of this Warrant, as the case may be, comply with the provisions of Section 4(a) of the Warrant Exercise
Agreement.

e)     
Representation by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring
this Warrant and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and
not with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act
or any applicable state securities law, except pursuant to sales registered or exempted under the Securities Act.

    	 	11	 

     

    

Section 5.Miscellaneous.

a)     
No Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3.

b)     
Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence
reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to
the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in
the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock
certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such
cancellation, in lieu of such Warrant or stock certificate.

c)     
Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of
any right required or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised
on the next succeeding Business Day.

d)     
Authorized Shares.

1.                 
During the period the Warrant is outstanding from and after the Initial Exercise Date, the Company covenants that it will
reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant
Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant
shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the
exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure
that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements
of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued
upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by
this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect
of any transfer occurring contemporaneously with such issue).

    	 	12	 

     

    

2.                 
Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without
limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger,
dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of
any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking
of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment.
Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the
amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be
necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon
the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents
from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations
under this Warrant.

3.                 
Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable
or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be
necessary from any public regulatory body or bodies having jurisdiction thereof.

e)     
Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant
shall be determined in accordance with the provisions of the Warrant Exercise Agreement.

f)      
Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not
registered and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities
laws.

g)     
Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part
of Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies, notwithstanding
the fact that all rights hereunder terminate on the Termination Date. If the Company willfully and knowingly fails to comply with
any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts
as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including
those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing
any of its rights, powers or remedies hereunder.

h)     
Notices. Any notice, request or other document required or permitted to be given or delivered to the Holder by the
Company shall be delivered in accordance with the notice provisions of the Warrant Exercise Agreement.

    	 	13	 

     

    

i)      
Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise
this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to
any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability
is asserted by the Company or by creditors of the Company.

j)      
Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of
damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would
not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees
to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

k)     
Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced
hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors
and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time
of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.

l)      
Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the
Company and the Holder.

m)  
Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such
provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions
or the remaining provisions of this Warrant.

n)     
Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose,
be deemed a part of this Warrant.

********************

(Signature Page Follows)

 

 

 

    	 	14	 

     

    

IN WITNESS WHEREOF, the Company has caused
this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

 

 

	 	
        AMYRIS, INC.

         

         

	 	
        By:__________________________________________

        Name:

        Title:

         

 

 

 

 

 

 

[Signature page to Warrant]

 

     

     

    

NOTICE OF EXERCISE

 

To:AMYRIS, INC.

 

(1)  
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant
(only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer
taxes, if any.

(2)  
Applicable Exercise Price: $

(3)  
Payment shall take the form of (check applicable box):

[ ] in lawful money of the United States; or

[ ] the cancellation of such number of Warrant Shares as
is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum
number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).

(4)  
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

_______________________________

 

 

The Warrant Shares shall be delivered to the following DWAC Account
Number:

 

_______________________________

 

_______________________________

 

_______________________________

 

(4) Accredited Investor. The undersigned is
an “accredited investor” as defined in Regulation D promulgated under the Securities Act of 1933, as amended.

 

[SIGNATURE OF HOLDER]

 

Name of Investing Entity: ______________________________________________________________

Signature of Authorized Signatory of Investing Entity: _______________________________________

Name of Authorized Signatory: __________________________________________________________

Title of Authorized Signatory: ___________________________________________________________

Date: ____________________________________________________________________________

 

 

     

     

    

ASSIGNMENT FORM

(To assign the foregoing Warrant, execute this form and supply
required information. Do not use this form to purchase shares.)

FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced
thereby are hereby assigned to

 

	Name:	
	 	(Please Print)
	 	 
	Address:	
	 	(Please Print)
	 	 
	Phone Number:	 
	 	 
	Email Address: 	 
	 	 
	Dated: _______________ __, ______	 
	 	 
	Holder’s Signature:                                                          	 
	 	 
	Holder’s Address:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00295-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00295-of-00352.parquet"}]]